Post-Operative Nausea And Vomiting Market Report 2026

Post-Operative Nausea And Vomiting Market Overview

• Post-Operative Nausea And Vomiting market size has reached to $2.25 billion in 2025 • Expected to grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Rising Surgical Procedures Driving Growth Due To Enhanced Healthcare Access And Advancements • Market Trend: Innovative Injectable Medications Enhancing Patient Safety And Prolonging Symptom Relief • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Post-Operative Nausea And Vomiting Market?

Post-operative nausea and vomiting (PONV) is a common complication that occurs within 24 to 48 hours after surgery, often resulting from anesthesia, pain medications, or the body's response to surgical stress. It can significantly affect a patient's recovery, causing discomfort, delayed healing, and an increased risk of complications like dehydration or electrolyte imbalance. The main treatment types of post-operative nausea and vomiting are serotonin antagonists, steroids, dopamine antagonists, neurokinin nk-1 receptor antagonists, non-pharmacological treatment, others. Serotonin antagonists refer to medications that block serotonin receptors, thereby preventing nausea and vomiting signals in the brain. The various route of administration includes oral, intravenous, transdermal, others with various patient demographics such as pediatric patients, adult patients, geriatric patients. The various surgical procedure types include orthopedic surgery, gynecological surgery, general surgery, cardiac surgery, ophthalmic surgery. These are also used by various end-users such as hospitals, ambulatory surgical centers, specialty clinics, others.

What Is The Post-Operative Nausea And Vomiting Market Growth Forecast?

The post-operative nausea and vomiting market size is expected to see strong growth in the next few years. It will grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growing demand for personalized anesthesia care, rising adoption of preventive antiemetic regimens, expansion of ambulatory surgical centers, increasing focus on patient satisfaction metrics, growing investments in perioperative care innovation. Major trends in the forecast period include increasing adoption of multimodal ponv management strategies, rising use of combination antiemetic therapies, growing focus on risk-stratified treatment protocols, expansion of non-pharmacological interventions, enhanced emphasis on patient comfort and recovery.

Global Post-Operative Nausea And Vomiting Market Segmentation

1) By Treatment Type: Serotonin Antagonists, Steroids, Dopamine Antagonists, Neurokinin NK-1 Receptor Antagonists, Non-pharmacological Treatment, Other Treatment Types 2) By Route Of Administration: Oral, Intravenous, Transdermal, Other Route Of Administrations 3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients 4) By Surgical Procedure Type: Orthopedic Surgery, Gynecological Surgery, General Surgery, Cardiac Surgery, Ophthalmic Surgery 5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users Subsegments: 1) By Serotonin Antagonists Type: Ondansetron, Granisetron, Palonosetron, Dolasetron, Tropisetron 2) By Steroids Type: Dexamethasone, Methylprednisolone, Hydrocortisone, Prednisolone, Betamethasone 3) By Dopamine Antagonists Type: Metoclopramide, Droperidol, Prochlorperazine, Domperidone, Chlorpromazine 4) By Neurokinin NK-1 Receptor Antagonists Type: Aprepitant, Fosaprepitant, Rolapitant, Netupitant, Casopitant 5) By Non-Pharmacological Treatment Type: Acupressure, Aromatherapy, Hypnotherapy, Electroacupuncture, Ginger Supplements 6) By Other Treatment Types: Antihistamines, Anticholinergics, Cannabinoids, Combination Therapy, Herbal & Natural Remedies

What Are The Drivers Of The Post-Operative Nausea And Vomiting Market?

The rising number of surgical procedures is expected to propel the growth of the post-operative nausea and vomiting market going forward. Surgical procedures are medical actions that use tools to find, treat, or remove damaged tissues, organs, or abnormalities by cutting or manipulating them. The number of surgical procedures is rising due to the advancements in medical technology, which have made surgeries safer, more effective, and minimally invasive, contributing to patient acceptance and wider applicability. Post-operative nausea and vomiting management enhances surgical procedures by improving patient comfort, reducing recovery time, minimizing the risk of complications, ensuring smoother post-operative care, and ultimately enhancing overall surgical outcomes. For instance, in November 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in the 2023–24 period, 771,600 patients were admitted for surgery from public hospital elective surgery waiting lists, representing a 4.9% increase compared to 2022–23. Therefore, the rising number of surgical procedures is driving the growth of the post-operative nausea and vomiting industry. The rising healthcare infrastructure is expected to propel the growth of the postoperative nausea and vomiting market going forward. Healthcare infrastructure refers to the physical facilities, equipment, and organizational systems that support the delivery of healthcare services, including hospitals, surgical centers, and medical technologies. The expansion of healthcare infrastructure is primarily driven by growing patient populations and increased demand for surgical procedures, as aging demographics and chronic disease prevalence require more hospital capacity and surgical interventions. The development of new hospitals and surgical facilities increases the volume of surgical procedures performed, which directly elevates the likelihood of postoperative complications requiring antiemetic management and treatment solutions. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the United States had 6,129 hospitals, representing a 0.591% increase from the previous year when there were 6,093 hospitals. Therefore, rising healthcare infrastructure is driving the growth of the post-operative nausea and vomiting industry.

Key Players In The Global Post-Operative Nausea And Vomiting Market

Major companies operating in the post-operative nausea and vomiting market are Pfizer Inc., Merck KGaA, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Baxter Corporation, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Inc., Fresenius Kabi AG, Eisai Co. Ltd., Dr. Reddy's Laboratories, Cipla Ltd., Alkem Laboratories Ltd., Eagle Pharmaceuticals Inc., Helsinn Healthcare SA, Heron Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Johnson And Johnson, Sanofi, Aurobindo Pharma Ltd., Lupin Limited

Global Post-Operative Nausea And Vomiting Market Trends and Insights

Major companies operating in the post-operative nausea and vomiting market are focusing on developing critical injectable medications, such as a regulatory-approved commercial launch of a pharmaceutical injectable to enhance antiemetic therapy in clinical settings. Regulatory-approved commercial launch of a pharmaceutical injectable refers to the introduction of an FDA- or authority-approved injectable drug into the market for clinical use, following completion of all required regulatory approvals and compliance processes. For instance, in July 2024, Avenacy, a US-based specialty pharmaceutical company, launched Palonosetron Hydrochloride Injection in 0.25 mg/5 mL single-dose vials to help healthcare providers reduce dosing errors and improve patient safety. This injection is indicated for preventing nausea and vomiting caused by chemotherapy and for managing postoperative nausea and vomiting (PONV) for up to 24 hours following surgery, offering a reliable treatment option for patients at risk of these conditions.

Regional Outlook

North America was the largest region in the post-operative nausea and vomiting market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Post-Operative Nausea And Vomiting Market?

The post-operative nausea and vomiting market consists of revenues earned by entities by providing services such as patient monitoring, anesthesia management, antiemetic drug administration, postoperative care, and clinical counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The post-operative nausea and vomiting market also includes sales of antiemetic drugs, intravenous fluids, nausea relief patches, oxygen therapy devices, and acupuncture kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Post-Operative Nausea And Vomiting Market Report 2026?

The post-operative nausea and vomiting market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the post-operative nausea and vomiting industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.